Figure 3.
ECNM. (A) Pearson correlation of the lactate dehydrogenase (LDH) levels with other disease parameters. ∗Significant P values adjusted by Holm-Bonferroni method. (B) Kaplan-Meier estimates of overall survival (OS) in patients with systemic mastocytosis (SM) stratified according to LDH levels (260-400 U/L vs ≥400 U/L); apower = 0.995. (C) Kaplan-Meier estimates of OS in patients with AdvSM according to LDH levels (260-400 U/L vs ≥400 U/L); bpower = 0.720. The P values refer to the log-rank test. ANC, absolute neutrophil count; β2MG, β2-microglobulin; Eos, eosinophil count; Hb, hemoglobin; KIT, KIT D816V allele burden; MC-I, mast cell infiltration; Monos, monocyte count; Plt, platelets; WBC, white blood cells.

ECNM. (A) Pearson correlation of the lactate dehydrogenase (LDH) levels with other disease parameters. ∗Significant P values adjusted by Holm-Bonferroni method. (B) Kaplan-Meier estimates of overall survival (OS) in patients with systemic mastocytosis (SM) stratified according to LDH levels (260-400 U/L vs ≥400 U/L); apower = 0.995. (C) Kaplan-Meier estimates of OS in patients with AdvSM according to LDH levels (260-400 U/L vs ≥400 U/L); bpower = 0.720. The P values refer to the log-rank test. ANC, absolute neutrophil count; β2MG, β2-microglobulin; Eos, eosinophil count; Hb, hemoglobin; KIT, KIT D816V allele burden; MC-I, mast cell infiltration; Monos, monocyte count; Plt, platelets; WBC, white blood cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal